Executive Order 13874: Modernizing the Regulatory Framework for Agricultural Biotechnology Products

President: Donald J. Trump

Directed Agriculture, EPA and FDA to review agricultural biotechnology regulations, reduce unnecessary overlap and provide a more predictable path for products, while maintaining their statutory safety responsibilities.

Status: In effect. Is Executive Order 13874 still in effect? Yes. Executive Order 13874 remains in effect. See Federal Register record.

What does Executive Order 13874 do?

USDA published its SECURE biotechnology rule in May 2020, changing APHIS review of certain engineered plants in phases through 2021.

Evidence review, September 23, 2026: USDA subsequently adopted its SECURE biotechnology regulation, updating parts of the oversight framework addressed by the order.

Administration position: The order directed coordination and regulatory review; USDA's SECURE rule is one subsequent agency action. EPA and FDA retain their own statutory authorities, and the rule does not establish that every product is exempt.
SignedJune 11, 2019
Original directionDirected Agriculture, EPA and FDA to review agricultural biotechnology regulations, reduce unnecessary overlap and provide a more predictable path for products, while maintaining their statutory safety responsibilities.
Later evidenceUSDA published its SECURE biotechnology rule in May 2020, changing APHIS review of certain engineered plants in phases through 2021.
Review dateSeptember 26, 2026

Before and after

Before the order

USDA, EPA and FDA shared oversight of agricultural biotechnology under their separate statutes; developers faced overlapping and sometimes uncertain review paths.

After the order

USDA published its SECURE biotechnology rule in May 2020, changing APHIS review of certain engineered plants in phases through 2021.

The order directed coordination and regulatory review; USDA's SECURE rule is one subsequent agency action. EPA and FDA retain their own statutory authorities, and the rule does not establish that every product is exempt.

Who had to do what

Agency / officialWhat the signed order directedDeadline / timing
Secretary of AgricultureIdentify streamlined or exempt regulatory treatment; jointly plan a unified biotechnology website; fund it through agreements; review genome-edited specialty-crop burdens and report progress; develop domestic consumer engagement and international outreach plans; consult on the trade strategy.Streamlining, website plan and domestic engagement within 180 days of June 11, 2019; international outreach within 120 days; progress every 90 days for two years.
EPA AdministratorIdentify streamlining and appropriate exemptions; jointly plan and support the website; review genome-edited specialty-crop burdens and report progress; consult on consumer engagement and international outreach.Streamlining and website plan within 180 days; progress every 90 days for two years; outreach within 120 days.
FDA CommissionerIdentify streamlining and appropriate exemptions; jointly plan and support the website; review genome-edited specialty-crop burdens and report progress; consult on consumer engagement and international outreach.Streamlining and website plan within 180 days; progress every 90 days for two years; outreach within 120 days.
Secretary of StateJointly develop the international biotechnology outreach strategy and consult on the trade strategy.Within 120 days.
United States Trade RepresentativeDevelop a trade strategy addressing biotechnology barriers and market access; consult on international outreach.Within 120 days.
Trade Policy Staff CommitteeConsult with USTR on the biotechnology trade strategy.Strategy due within 120 days.

Source: Signed Federal Register text.

Later developments

Later authority: USDA published its SECURE biotechnology rule in May 2020, changing APHIS review of certain engineered plants in phases through 2021. (May 18, 2020)

What happened next

EO 13874 signed.

USDA published its SECURE biotechnology rule in May 2020, changing APHIS review of certain engineered plants in phases through 2021.

Guide checked against signed order and later official evidence.